In this context, here, we detected a significant overexpression (* p < 0.05 vs. CTR) of PPAR-γ protein after 24 and 48 h of treatment with exosomes derived from NAFLD patients compared with the control cells (Figure 6 Panel A,B, respectively). Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.